Siegel Caroline H, Jannat-Khah Deanna, Mikhaylov Avi L, Fritz Patrick, Abramson Erika L, Sammaritano Lisa R, Pan Nancy
Hospital for Special Surgery and Weill Cornell Medicine, New York, New York.
Hospital for Special Surgery, New York, New York.
ACR Open Rheumatol. 2025 Jan;7(1):e11775. doi: 10.1002/acr2.11775.
This quality improvement initiative aimed to increase the rate of provider screening and documentation of contraception use for reproductive-aged women seen in an academic rheumatology fellows' clinic to >50% by 24 weeks, with sustained improvement at one year.
With a multidisciplinary team, we devised and implemented six interventional cycles over 24 weeks informed by key stakeholder survey responses. The primary outcome measure was the percentage of eligible visits with contraception information documented in the structured electronic health record field. The smoking status documentation rate was tracked as a balancing measure, and the percentage of contraception documenters who were non-medical doctor (MD) clinical staff, the target group for the intervention, was tracked as a process measure. Outcome, process, and balancing measures were assessed every two weeks over one year.
Over 24 weeks, the rate of contraception documentation increased from 11% to 54% (median 30%), and the median smoking status documentation rate was 88% (68%-97% range); the median rate of non-MD clinical staff documenters was 92% (70%-100% range). Interventions included an introductory educational session with documentation instruction and scripts to guide screening, email reminders from nursing leadership, and interim educational sessions. At one year, the contraception documentation rate was sustained at 50%.
A multicycle educational intervention led to an increase in the contraception documentation rate from 11% to 54% for reproductive-aged women seen in an academic rheumatology fellows' clinic over 24 weeks, with sustained improvement at one year. Future interventions will focus on increasing contraception counseling and referrals for patients in rheumatology clinics who were high risk.
这项质量改进计划旨在将学术性风湿病专科门诊中育龄女性避孕措施使用情况的筛查及记录比例在24周内提高至50%以上,并在一年时保持持续改善。
我们与一个多学科团队合作,根据关键利益相关者的调查反馈,在24周内设计并实施了六个干预周期。主要结局指标是结构化电子健康记录字段中记录有避孕信息的合格就诊比例。吸烟状况记录率作为一项平衡指标进行跟踪,记录避孕信息的非医生临床工作人员(干预的目标群体)比例作为一项过程指标进行跟踪。在一年时间里,每两周评估一次结局、过程和平衡指标。
在24周内,避孕措施记录率从11%提高到了54%(中位数为30%),吸烟状况记录率中位数为88%(范围为68%-97%);非医生临床工作人员记录者的中位数比例为92%(范围为70%-100%)。干预措施包括开展一次带有记录指导和筛查脚本的入门教育课程、护理领导层发送的电子邮件提醒以及中期教育课程。在一年时,避孕措施记录率维持在50%。
一项多周期教育干预使学术性风湿病专科门诊中育龄女性的避孕措施记录率在24周内从11%提高到了54%,并在一年时保持持续改善。未来的干预将侧重于增加对风湿病门诊高危患者的避孕咨询和转诊。